Fourth-quarter earnings set to be best of 2023

Traders work at the New York Stock Exchange (NYSE) in New York City, USA, on February 1, 2024. Brendan McDermid…

J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2 billion

An entrance sign to the Johnson & Johnson campus displays its logo in Irvine, California, on August 28, 2019. Marcos…